VFC
61
18
MAR
68
3
LMT
60
5
SWK
48
6
PPG
50
2
TRIP
52
8
TXT
68
3
AON
56
4
EL
42
9
TSCO
55
2
VLO
46
3
COST
47
2
JCI
56
2
EQIX
67
-5
R
72
4
ROP
54
4
DNB
52
4
UAL
53
8
BF.B
48
2
ETN
72
5
VFC
61
18
MAR
68
3
LMT
60
5
SWK
48
6
PPG
50
2
TRIP
52
8
TXT
68
3
AON
56
4
EL
42
9
TSCO
55
2
VLO
46
3
COST
47
2
JCI
56
2
EQIX
67
-5
R
72
4
ROP
54
4
DNB
52
4
UAL
53
8
BF.B
48
2
ETN
72
5
Financhill
Back

Merus NV Vs. Apellis Pharmaceuticals Industry Stock Comparison

Buy
66

MRUS
Merus NV

Last Price:
$50.01
Seasonality Move:
7.97%
Sell
33

APLS
Apellis Pharmaceuticals

Last Price:
$16.80
Seasonality Move:
2.29%
Buy
66
Merus NV (MRUS) is a Buy

Is Merus NV a Buy, Sell or Hold?

  • The current Merus NV [MRUS] share price is $50.01. The Score for MRUS is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • MRUS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
33
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $16.80. The Score for APLS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MRUS Stock Price Chart

What is Merus NV's stock price today?

  • The Merus NV share price today is $50.01
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MRUS is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $16.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.

MRUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.6 Buy
Relative Strength Index (14 RSI): 59.92 Buy
Chaikin Money Flow: -940132 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.08 - 47.34) Buy
Bollinger Bands (100): (39.89 - 46.35) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.7 Sell
Relative Strength Index (14 RSI): 39.3 Sell
Chaikin Money Flow: -1528116 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.89 - 18.97) Sell
Bollinger Bands (100): (18.95 - 29.29) Sell

MRUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.96 Buy
20-day SMA: 43.63 Buy
50-day SMA: 43.31 Buy
200-day SMA: 46.11 Buy
8-day EMA: 47.1 Buy
20-day EMA: 44.67 Buy
50-day EMA: 43.74 Buy
200-day EMA: 44.44 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.5 Sell
20-day SMA: 17.98 Sell
50-day SMA: 19.65 Sell
200-day SMA: 28.35 Sell
8-day EMA: 17.31 Sell
20-day EMA: 17.82 Sell
50-day EMA: 19.84 Sell
200-day EMA: 28.43 Sell

Merus NV Earnings Growth & MRUS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.31 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.90 per share, and an increase next year of $0.14 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.19 per share, and an increase next year of $1.21 per share.

Merus NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):